Israel Englander’s Alpine Immune Sciences Inc ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,438
| Closed | -$572K | – | 6743 |
|
|
2024
Q1 | $572K | Sell |
14,438
-258,628
| -95% | -$7.63M | ﹤0.01% | 4728 |
|
|
2023
Q4 | $5.2M | Buy |
273,066
+190,140
| +229% | +$2.64M | ﹤0.01% | 2755 |
|
|
2023
Q3 | $950K | Sell |
82,926
-33,249
| -29% | -$409K | ﹤0.01% | 4221 |
|
|
2023
Q2 | $1.19M | Buy |
+116,175
| New | +$1.05M | ﹤0.01% | 3907 |
|
|
2021
Q2 | – | Sell |
-96,017
| Closed | -$1.02M | – | 7268 |
|
|
2021
Q1 | $1.02M | Buy |
96,017
+50,246
| +110% | +$626K | ﹤0.01% | 4210 |
|
|
2020
Q4 | $577K | Sell |
45,771
-287
| -0.6% | -$2.82K | ﹤0.01% | 4090 |
|
|
2020
Q3 | $405 | Buy |
+46,058
| New | +$421K | ﹤0.01% | 3679 |
|
|
2018
Q4 | – | Sell |
-10,694
| Closed | -$68K | – | 4280 |
|
|
2018
Q3 | $68K | Buy |
+10,694
| New | +$74.8K | ﹤0.01% | 3778 |
|
|
2018
Q2 | – | Sell |
-13,705
| Closed | -$110K | – | 4274 |
|
|
2018
Q1 | $110K | Sell |
13,705
-4,567
| -25% | -$45.1K | ﹤0.01% | 3472 |
|
|
2017
Q4 | $205K | Buy |
+18,272
| New | +$199K | ﹤0.01% | 3522 |
|
|
2017
Q2 | – | Sell |
-15,134
| Closed | -$177K | – | 3966 |
|
|
2017
Q1 | $177K | Buy |
15,134
+5,113
| +51% | +$51.8K | ﹤0.01% | 3239 |
|
|
2016
Q4 | $90K | Buy |
+10,021
| New | +$200K | ﹤0.01% | 3208 |
|
|
2015
Q4 | – | Sell |
-3,572
| Closed | -$185K | – | 3845 |
|
|
2015
Q3 | $185K | Buy |
+3,572
| New | +$235K | ﹤0.01% | 3140 |
|
Israel Englander's ALPN Position: Q2 2024 in Review
Israel Englander sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 14,438 shares — an estimated $572K sold.
Israel Englander first reported a position in ALPN in Q3 2015 and held it in 13 quarters. The position peaked at $5.2M in Q4 2023. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.
- Israel Englander reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
- Israel Englander sold 14,438 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $572K.
- Israel Englander first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 13 quarters.
- Israel Englander's Alpine Immune Sciences Inc position peaked at $5.2M in Q4 2023.
- 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.